235 related articles for article (PubMed ID: 35779656)
1. An update on dual targeting strategy for cancer treatment.
Taghipour YD; Zarebkohan A; Salehi R; Rahimi F; Torchilin VP; Hamblin MR; Seifalian A
J Control Release; 2022 Sep; 349():67-96. PubMed ID: 35779656
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting salinomycin-loaded smart nanomicelles for enhanced accumulation and therapeutic outcome in breast cancer.
Davatgaran Taghipour Y; Salehi R; Zarebkohan A; Zakeri Z; Khordadmehr M; Saeedi Honar Y; Torchilin VP
Int J Pharm; 2023 Jul; 642():123095. PubMed ID: 37268031
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Tian H; Zhang T; Qin S; Huang Z; Zhou L; Shi J; Nice EC; Xie N; Huang C; Shen Z
J Hematol Oncol; 2022 Sep; 15(1):132. PubMed ID: 36096856
[TBL] [Abstract][Full Text] [Related]
4. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
6. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
7. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
Wu F; Qiu F; Wai-Keong SA; Diao Y
Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
[TBL] [Abstract][Full Text] [Related]
8. Smart Targeting To Improve Cancer Therapeutics.
Morales-Cruz M; Delgado Y; Castillo B; Figueroa CM; Molina AM; Torres A; Milián M; Griebenow K
Drug Des Devel Ther; 2019; 13():3753-3772. PubMed ID: 31802849
[TBL] [Abstract][Full Text] [Related]
9. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
10. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
Sun Y; Li Y; Shi S; Dong C
Molecules; 2021 May; 26(9):. PubMed ID: 34062992
[TBL] [Abstract][Full Text] [Related]
11. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
[TBL] [Abstract][Full Text] [Related]
13. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
14. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
[TBL] [Abstract][Full Text] [Related]
15. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
17. ATP/pH Dual Responsive Nanoparticle with d-[des-Arg
Zhang Y; Lu Y; Wang F; An S; Zhang Y; Sun T; Zhu J; Jiang C
Small; 2017 Jan; 13(3):. PubMed ID: 27775872
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.
El-Sawy HS; Al-Abd AM; Ahmed TA; El-Say KM; Torchilin VP
ACS Nano; 2018 Nov; 12(11):10636-10664. PubMed ID: 30335963
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
Doolittle E; Peiris PM; Doron G; Goldberg A; Tucci S; Rao S; Shah S; Sylvestre M; Govender P; Turan O; Lee Z; Schiemann WP; Karathanasis E
ACS Nano; 2015 Aug; 9(8):8012-21. PubMed ID: 26203676
[TBL] [Abstract][Full Text] [Related]
20. Can dual-ligand targeting enhance cellular uptake of nanoparticles?
Xia QS; Ding HM; Ma YQ
Nanoscale; 2017 Jul; 9(26):8982-8989. PubMed ID: 28447687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
